Respiratory Infections News

Moderna said Monday that data from a phase 2/3 trial showed that its bivalent COVID-19 booster shot triggers a higher antibody response against SARS-CoV-2 omicron subvariants than its original vaccine.

Although clinical and cycle threshold value assessment can distinguish COVID-19 reinfection from detecting virus from a prior infection, it failed to identify 33% of genomically supported reinfections, according to a recent study.

For adults in the U.K., preexisting neuropsychiatric conditions and having a prescription for a related treatment carried a significantly increased risk of severe outcomes from COVID-19 and other severe acute respiratory infections.

SARS-CoV-2-related neurologic effects endured among children and adolescents in the United States who were hospitalized in 2021 for COVID-19 or multisystem inflammatory syndrome, researchers reported in JAMA Neurology.

Boston-area school districts that lifted mask mandates earlier this year experienced nearly 45 more cases of COVID-19 per 1,000 students and staff than school districts that kept their mandates in place, a study found.

Social determinants of health, including lower socioeconomic status and a higher proportion of racially minoritized groups, correlated with higher likelihood of COVID-19-related death, according to a recent study in Clinical Infectious Diseases.

Respiratory tract and total body burden of SARS-CoV-2 infection could predict how long patients will take to recover and provide insight into long COVID, according to a recent study published in Clinical Infectious Diseases.

Novavax on Monday said that its omicron subvariant vaccine candidate and original COVID-19 vaccine both performed well in a phase 3 trial testing three vaccines as a second booster dose.

CHICAGO — COVID-19-induced hyposmia eliminated odor-induced migraine headaches in an older adult, a case study presented at the 2022 American Neurological Association’s annual meeting showed.

CHICAGO — Igor J. Koralnik, MD, discusses highlights from his presentation at the 2022 American Neurological Association’s annual meeting on long COVID and its effect on the nervous system.